FDA Approves Penpulimab-kcqx for Non-keratinizing Nasopharyngeal Carcinoma By Ogkologos - May 23, 2025 271 0 Facebook Twitter Google+ Pinterest WhatsApp Evidence for efficacy is based on the results from the Study AK105-304 and Study AK105-202 Source RELATED ARTICLESMORE FROM AUTHOR FDA Approves Gemcitabine Intravesical System for Non-Muscle Invasive Bladder Cancer ESMO Calls for Robust EU Taxation of Tobacco Products, Aiming to Prevent Cancers Attributable to Tobacco Use EMA Recommends Granting a Marketing Authorisation for Biosimilar Pegfilgrastim MOST POPULAR Breast Cancer Survivor Driven from Her Home by Noxious Gases from... June 11, 2021 Olivia Newton-John Shares Positive News On Breast Cancer: “I’m Winning Over... January 28, 2020 Husband Turns Wife’s Inspiring Poem for Her Daughters into a Book... February 25, 2020 Join the Great American Smokeout for a Healthier Tomorrow November 14, 2023 Load more HOT NEWS Should Surgery And Radiation Be The Standard Treatment For DCIS? The... Daughter And Her Terminally Ill Dad Go On Bucket List Adventures... The award-winning team transforming breast cancer treatment Zanidatamab Demonstrates Meaningful Clinical Benefit with a Manageable Safety Profile in...
